ReviewStem cells translational medicine2020

Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.

B Linju Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.